Anxiety Disorders and Coronary Heart Disease
Main Article Content
Abstract
According to the World Health Organization, mortality from cardiovascular diseases remains the highest in comparison with economically developed countries among both men and women. In recent years, the prevalence of the main risk factors for cardiovascular diseases in Uzbekistan has not changed significantly, at the same time, the level of emotional stress has increased significantly. The growth of psychosocial stress in the population is accompanied by an increase in the level of emotional tension, anxiety among the population. The prevalence of anxiety disorders in the population, according to various authors, ranges from 3 to 30%. Anxiety increases after mental trauma, acute and chronic somatic diseases and neuropsychiatric diseases. Thus, the severity of anxiety and the level of anxiety, reflecting the degree of personal distress, can be a kind of marker of chronic psychological stress. With an increase in the level of anxiety, there is a change in the activity of sympathoadreal, hypothalamic-pituitary–adrenal and renin–angiotensin–aldosterone systems -Moreover, it is naturally accompanied by changes in carbohydrate, protein, and lipid metabolism, procoagulant shifts in hemostasis, and impaired vascular endothelial function. All these disorders can lead to increased progression of atherosclerosis, increased coronary vascular tone, increased instability of atherosclerotic plaques, a tendency to thrombosis and contribute to the aggravation of the course of coronary heart disease (CHD). At the same time, the peculiarities of the influence of anxiety disorders on the course of coronary heart disease and quality of life have not been studied enough
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Zikriyaevna, S. G., & Muhtorovna, E. M. (2019). The features of the early diagnostics of osteoporosis in patients with rheumatoid arthritis. Достижения науки и образования, (12 (53)), 110-112.
Эргашова, М. М., & Шодикулова, Г. З. (2021). РЕВМАТОИД АРТРИТ ВА ИККИЛАМЧИ ОСТЕОАРТРОЗ КАСАЛЛИГИ БОР БЕМОРЛАРДА ЮРАК ГЕМОДИНАМИКАСИНИНГ ЎЗИГА ХОС ХУСУСИЯТЛАРИ. ЖУРНАЛ БИОМЕДИЦИНЫ И ПРАКТИКИ, 6(1).
Xaydarov, S. N., & Normatov, M. B. (2021). DETERMINATION OF IRON DEFICIENCY ANEMIA AT THE PREGNANCY PERIOD. Scientific progress, 2(4), 325-327.
Toshtemirovna, E. M. M., Nizamitdinovich, K. S., Tadjiyevich, X. A., & Xudoyberdiyevich, G. X. (2022). ASSESSMENT OF RENAL DYSFUNCTION IN PATIENTS WITH CHRONIC HEART FAILURE.
Alisherovna, K. M., Davranovna, M. H., & Nizametdinovich, K. S. (2022). Chronic Heart Failure in Women. CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES, 3(1), 21-25.
Makhmudova, K. D., & Gaffarov, H. H. (2021, February). STUDYING THE LIVER FUNCTION IN BURN RECONVALESCENTS. In Archive of Conferences (Vol. 15, No. 1, pp. 208-210).
Тоиров, Д. Р., & Махмудова, Х. Д. (2021). ПОДАГРА КАСАЛЛИГИ БИЛАН ОҒРИГАН БЕМОРЛАРДА ЮРАК ҚОН-ТОМИР ЗАРАРЛАНИШЛАРИ. Scientific progress, 2(2), 242-249.
Toshtemirovna, E. M. M., Alisherovna, K. M., Totlibayevich, Y. S., & Duskobilovich, B. S. (2022). THE VALUE OF XANTHINE IN CHRONIC HEART FAILURE. Spectrum Journal of Innovation, Reforms and Development, 4, 24-29.
Erkinovna, K. Z., Davranovna, M. K., Toshtemirovna, E. M. M., & Xudoyberdiyevich, G. X. (2022). CORRECTION OF COMPLICATIONS IN CHRONIC HEART FAILURE DEPENDING ON THE FUNCTIONAL STATE OF THE KIDNEYS. Web of Scientist: International Scientific Research Journal, 3(5), 565-575.
Yarmatov, S. T., & Xusainova, M. A. (2021). YURAK ISHEMIK KASALLIGI MAVJUD BO’LGAN BEMORLARDA. Scientific progress, 2(3), 785-791.
Yarmatov, S. T., & Yarmahammadov, U. K. (2022). Semizlik–Zamonaviy Tibbiyotda Dolzarb Muammo Sifatida Qolmoqda. Scientific progress, 3(4), 1196-1203.
Yarmatov, S. T. (2021). YURAK ISHEMIK KASALLIGI VA BACHADON MIOMASI BO'LGAN BEMORLARNI DAVOLASHDA ANTIKOUGULYANT VA ANTITROMBOSITAR TERAPIYANI O’TKAZISH BO’YICHA KLINIK KUZATUVNI OLIB BORISH. Scientific progress, 2(3), 792-797.
Khabibovna, Y. S., & Buribaevich, N. M. (2020). STUDY OF PARAMETERS OF CENTRAL HEMODYNAMICS IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS. Достижения науки и образования, (13 (67)), 57-59.
Норматов, М. Б. (2022). EFFICACY OF AMLODIPINE IN ARTERIAL HYPERTENSION COMBINED WITH TYPE 2 DIABETES MELLITUS. Журнал кардиореспираторных исследований, 3(1).
Buribayevich, N. M. (2022). DIASTOLIC DYSFUNCTION AND REMODELING LEFT VENTRICLE DEPENDING ON THE CONTROL GLYCEMIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Spectrum Journal of Innovation, Reforms and Development, 7, 96-100.
Ярмухаммедова, С. (2020). ОЦЕНКА ПРИЗНАКОВ ДИАСТОЛИЧЕСКОЙ ДИСФУНКЦИИ ПРАВОГО ЖЕЛУДОЧКА У БОЛЬНЫХ С АРТЕРИАЛЬНОЙ ГИПЕРТОНИЕЙ. Журнал кардиореспираторных исследований, 1(2), 88-92.
Yarmukhamedova, S. (2020). SURUNKALI GLOMERULONEFRIT BILAN OG ‘RIGAN BEMORLARDA ARTERIAL QON BOSIMINING SUTKALIK MONITORING KO ‘RSATKICHLARINI BAXOLASH. Журнал кардиореспираторных исследований, 1(1), 103-108.
Хусаинова, М. (2021). CHRONIC HEART FAILURE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS. Журнал кардиореспираторных исследований, 2(4), 67-69.
Хайдарова, З. (2021). ЭНТРОПИЯ И НАРУШЕНИЯ СЕРДЕЧНОГО РИТМА У БОЛЬНЫХ, ПЕРЕНЕСШИХ ИНФАРКТ МИОКАРДА. Журнал кардиореспираторных исследований, 2(4), 59-62.
Nazarov, F. Y., & Xaydarova, Z. E. (2022). OSHQOZON VA ICHAK YARA KASALLIKLARI BOR BEMORLARDA SUYAKLAR MINERAL ZICHLIGINING BUZILISHI. Oriental renaissance: Innovative, educational, natural and social sciences, 2(Special Issue 4-2), 1037-1044.